FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.21  |  FHIR Version n/a  User: [n/a]

37359211000001108: Circadin 2mg modified-release tablets (Mawdsley-Brooks & Company Ltd) 30 tablet (product)

Status: current, Not sufficiently defined by necessary conditions definition status. Date: 10-Jul 2019. Module: SNOMED CT United Kingdom drug extension module

Descriptions:

Id Description Lang Type Status Case? Module
304841000001117 Circadin 2mg modified-release tablets (Mawdsley-Brooks & Company Ltd) 30 tablet en Synonym Active Entire term case sensitive SNOMED CT United Kingdom drug extension module
304851000001119 Circadin 2mg modified-release tablets (Mawdsley-Brooks & Company Ltd) 30 tablet (product) en Fully specified name Active Entire term case sensitive SNOMED CT United Kingdom drug extension module

0 descendants.

Expanded Value Set

Outbound Relationships Type Target Active Characteristic Refinability Group Values
Circadin 2mg modified-release tablets (Mawdsley-Brooks & Company Ltd) 30 tablet Is a Actual medicinal product pack true Inferred relationship Existential restriction modifier
Circadin 2mg modified-release tablets (Mawdsley-Brooks & Company Ltd) 30 tablet Is a Melatonin 2mg modified-release tablets 30 tablet true Inferred relationship Existential restriction modifier
Circadin 2mg modified-release tablets (Mawdsley-Brooks & Company Ltd) 30 tablet Discontinued indicator Never discontinued false Inferred relationship Existential restriction modifier
Circadin 2mg modified-release tablets (Mawdsley-Brooks & Company Ltd) 30 tablet Has AMP Circadin 2mg modified-release tablets (Mawdsley-Brooks & Company Ltd) true Inferred relationship Existential restriction modifier
Circadin 2mg modified-release tablets (Mawdsley-Brooks & Company Ltd) 30 tablet Legal category Prescription only medicine - legal category (qualifier value) true Inferred relationship Existential restriction modifier
Circadin 2mg modified-release tablets (Mawdsley-Brooks & Company Ltd) 30 tablet Has dispensed dose form Modified-release oral tablet true Inferred relationship Existential restriction modifier
Circadin 2mg modified-release tablets (Mawdsley-Brooks & Company Ltd) 30 tablet VMP prescribing status (attribute) VMP valid as a prescribable product true Inferred relationship Existential restriction modifier
Circadin 2mg modified-release tablets (Mawdsley-Brooks & Company Ltd) 30 tablet VMP non-availability indicator Re-introduced true Inferred relationship Existential restriction modifier
Circadin 2mg modified-release tablets (Mawdsley-Brooks & Company Ltd) 30 tablet Has specific active ingredient Melatonin true Inferred relationship Existential restriction modifier
Circadin 2mg modified-release tablets (Mawdsley-Brooks & Company Ltd) 30 tablet Has NHS dm+d (dictionary of medicines and devices) controlled drug category Controlled drug category No Controlled Drug Status true Inferred relationship Existential restriction modifier
Circadin 2mg modified-release tablets (Mawdsley-Brooks & Company Ltd) 30 tablet Has excipient Excipient not declared true Inferred relationship Existential restriction modifier
Circadin 2mg modified-release tablets (Mawdsley-Brooks & Company Ltd) 30 tablet Has NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction indicator NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction none true Inferred relationship Existential restriction modifier
Circadin 2mg modified-release tablets (Mawdsley-Brooks & Company Ltd) 30 tablet Has NHS dm+d (dictionary of medicines and devices) parallel import indicator Parallel import true Inferred relationship Existential restriction modifier
Circadin 2mg modified-release tablets (Mawdsley-Brooks & Company Ltd) 30 tablet Discontinued indicator Discontinued AMPP(qualifier value) true Inferred relationship Existential restriction modifier
Inbound Relationships Type Active Source Characteristic Refinability Group

This concept is not in any reference sets

Back to Start